Provided by Tiger Fintech (Singapore) Pte. Ltd.

CVS Health

66.78
+0.55000.83%
Post-market: 67.020.2400+0.36%19:58 EDT
Volume:9.28M
Turnover:617.77M
Market Cap:84.48B
PE:15.93
High:67.16
Open:66.31
Low:65.84
Close:66.23
Loading ...
Dec 13, 2021

Major Issues Report

8-K - Current report
Dec 03, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Dec 01, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 19, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 19, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 19, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 19, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 19, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 19, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 19, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 18, 2021

Major Issues Report

8-K - Current report
Nov 03, 2021

Major Issues Report

8-K - Current report
Nov 03, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 23, 2021

Major Issues Report

8-K - Current report
Aug 18, 2021

Major Issues Report

8-K - Current report
Aug 11, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Aug 04, 2021

Major Issues Report

8-K - Current report
Aug 04, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]